166 related articles for article (PubMed ID: 32302613)
1. Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes.
Iversen R; Amundsen SF; Kleppa L; du Pré MF; Stamnaes J; Sollid LM
Gastroenterology; 2020 Aug; 159(2):788-790. PubMed ID: 32302613
[No Abstract] [Full Text] [Related]
2. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
3. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
4. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
[TBL] [Abstract][Full Text] [Related]
5. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
6. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
7. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease as a model of gastrointestinal inflammation.
Sollid LM
J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S41-2. PubMed ID: 15805849
[No Abstract] [Full Text] [Related]
9. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/- mouse.
Szondy Z; Korponay-Szabó I; Király R; Fésüs L
Adv Enzymol Relat Areas Mol Biol; 2011; 78():295-345. PubMed ID: 22220477
[No Abstract] [Full Text] [Related]
11. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
12. Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes.
Dørum S; Steinsbø Ø; Bergseng E; Arntzen MØ; de Souza GA; Sollid LM
Sci Rep; 2016 May; 6():25565. PubMed ID: 27146306
[TBL] [Abstract][Full Text] [Related]
13. Gluten in infants and celiac disease risk.
Andrén Aronsson C; Kurppa K; Agardh D
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):669-70. PubMed ID: 27027529
[No Abstract] [Full Text] [Related]
14. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
16. The adaptive immune response in celiac disease.
Qiao SW; Iversen R; Ráki M; Sollid LM
Semin Immunopathol; 2012 Jul; 34(4):523-40. PubMed ID: 22535446
[TBL] [Abstract][Full Text] [Related]
17. Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event?
Farrace MG; Picarelli A; Di Tola M; Sabbatella L; Marchione OP; Ippolito G; Piacentini M
Cell Death Differ; 2001 Jul; 8(7):767-70. PubMed ID: 11464221
[No Abstract] [Full Text] [Related]
18. ["And nevertheless...autoimmunity"--celiac disease and the antibodies to tissue transglutaminase].
Landau YE; Shoenfeld Y
Harefuah; 2000 Jan; 138(2):122-6. PubMed ID: 10883074
[No Abstract] [Full Text] [Related]
19. Autoimmunity provoked by foreign antigens.
Iversen R; Sollid LM
Science; 2020 Apr; 368(6487):132-133. PubMed ID: 32273455
[No Abstract] [Full Text] [Related]
20. Antibodies to human tissue transglutaminase for the diagnosis of celiac disease.
Vitoria JC; Arrieta A; Ortiz L; Ayesta A
J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):349-50. PubMed ID: 11593137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
